Skip to main content
SpringerLink
Log in

Cutaneous Adverse Drug Reactions: Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis

  • Chapter
  • First Online:
Immunology of the Skin

Abstract

Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening cutaneous reactions caused by drugs or infections and exhibiting widespread epidermal necrosis. SJS/TEN might be a specific immune reaction initiated by cytotoxic T lymphocytes via an HLA-restricted pathway. Recent advances in pharmacogenomic studies have provided evidence for genetic predispositions to SJS/TEN. Toward explaining how drug-specific (immunological) reactions induce adverse drug reactions, several concepts have been proposed: in addition to the hapten concept and the p-i concept, there is the idea that drugs alter the antigen by binding to the HLA pocket. With regard to keratinocyte death, several cell death mediators, such as FasL and granulysin, have been proposed as playing a role in SJS/TEN pathogenesis. If SJS/TEN is simply the most extreme reaction on a spectrum of drug reactions, then regulating the immunological reaction could influence the severity of the adverse drug reaction. A subset of T lymphocytes, including regulatory T cells, also might play a role in SJS/TEN.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Abe R, Shimizu T, Shibaki A, Nakamura H, Watanabe H, Shimizu H (2003) Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand. Am J Pathol 162(5):1515–1520

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Abe R, Yoshioka N, Murata J, Fujita Y, Shimizu H (2009) Granulysin as a marker for early diagnosis of the Stevens-Johnson syndrome. Ann Intern Med 151(7):514–515

    Article  PubMed  Google Scholar 

  3. Azukizawa H, Kosaka H, Sano S, Heath WR, Takahashi I, Gao XH, Sumikawa Y, Okabe M, Yoshikawa K, Itami S (2003) Induction of T-cell-mediated skin disease specific for antigen transgenically expressed in keratinocytes. Eur J Immunol 33(7):1879–1888

    Article  CAS  PubMed  Google Scholar 

  4. Azukizawa H, Sano S, Kosaka H, Sumikawa Y, Itami S (2005) Prevention of toxic epidermal necrolysis by regulatory T cells. Eur J Immunol 35(6):1722–1730

    Article  CAS  PubMed  Google Scholar 

  5. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129(1):92–96

    Article  CAS  PubMed  Google Scholar 

  6. Chen P, Lin JJ, Lu CS, Ong CT, Hsieh PF, Yang CC, Tai CT, Wu SL, Lu CH, Hsu YC, Yu HY, Ro LS, Lu CT, Chu CC, Tsai JJ, Su YH, Lan SH, Sung SF, Lin SY, Chuang HP, Huang LC, Chen YJ, Tsai PJ, Liao HT, Lin YH, Chen CH, Chung WH, Hung SI, Wu JY, Chang CF, Chen L, Chen YT, Shen CY (2011) Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N Engl J Med 364(12):1126–1133

    Article  CAS  PubMed  Google Scholar 

  7. Chessman D, Kostenko L, Lethborg T, Purcell AW, Williamson NA, Chen Z, Kjer-Nielsen L, Mifsud NA, Tait BD, Holdsworth R, Almeida CA, Nolan D, Macdonald WA, Archbold JK, Kellerher AD, Marriott D, Mallal S, Bharadwaj M, Rossjohn J, McCluskey J (2008) Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity. Immunity 28(6):822–832

    Article  CAS  PubMed  Google Scholar 

  8. Chung WH, Hung SI (2012) Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis. J Dermatol Sci 66(3):190–196

    Article  CAS  PubMed  Google Scholar 

  9. Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT (2004) Medical genetics: a marker for Stevens-Johnson syndrome. Nature 428(6982):486

    Article  CAS  PubMed  Google Scholar 

  10. Chung WH, Hung SI, Yang JY, Su SC, Huang SP, Wei CY, Chin SW, Chiou CC, Chu SC, Ho HC, Yang CH, Lu CF, Wu JY, Liao YD, Chen YT (2008) Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 14(12):1343–1350

    Article  CAS  PubMed  Google Scholar 

  11. Di Pascuale MA, Espana EM, Liu DT, Kawakita T, Li W, Gao YY, Baradaran-Rafii A, Elizondo A, Raju VK, Tseng SC (2005) Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome. Ophthalmology 112(5):904–912

    Article  PubMed  Google Scholar 

  12. Fujita Y, Yoshioka N, Abe R, Murata J, Hoshina D, Mae H, Shimizu H (2011) Rapid immunochromatographic test for serum granulysin is useful for the prediction of Stevens-Johnson syndrome and toxic epidermal necrolysis. J Am Acad Dermatol 65(1):65–68

    Article  CAS  PubMed  Google Scholar 

  13. Fujiyama T, Kawakami C, Sugita K, Kubo-Kabashima R, Sawada Y, Hino R, Nakamura M, Shimauchi T, Ito T, Kabashima K, Hashizume H, Tokura Y (2014) Increased frequencies of Th17 cells in drug eruptions. J Dermatol Sci 73(1):85–88. doi:10.1016/j.jdermsci.2013.08.008

    Article  CAS  PubMed  Google Scholar 

  14. Hanafusa T, Azukizawa H, Matsumura S, Katayama I (2012) The predominant drug-specific T-cell population may switch from cytotoxic T cells to regulatory T cells during the course of anticonvulsant-induced hypersensitivity. J Dermatol Sci 65(3):213–219

    Article  CAS  PubMed  Google Scholar 

  15. Hari Y, Frutig-Schnyder K, Hurni M, Yawalkar N, Zanni MP, Schnyder B, Kappeler A, von Greyerz S, Braathen LR, Pichler WJ (2001) T cell involvement in cutaneous drug eruptions. Clin Exp Allergy 31(9):1398–1408

    Article  CAS  PubMed  Google Scholar 

  16. Horton H, Weston SD, Hewitt CR (1998) Allergy to antibiotics: T-cell recognition of amoxicillin is HLA-DR restricted and does not require antigen processing. Allergy 53(1):83–88

    Article  CAS  PubMed  Google Scholar 

  17. Illing PT, Vivian JP, Dudek NL, Kostenko L, Chen Z, Bharadwaj M, Miles JJ, Kjer-Nielsen L, Gras S, Williamson NA, Burrows SR, Purcell AW, Rossjohn J, McCluskey J (2012) Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature 486(7404):554–558

    CAS  PubMed  Google Scholar 

  18. Kaspar AA, Okada S, Kumar J, Poulain FR, Drouvalakis KA, Kelekar A, Hanson DA, Kluck RM, Hitoshi Y, Johnson DE, Froelich CJ, Thompson CB, Newmeyer DD, Anel A, Clayberger C, Krensky AM (2001) A distinct pathway of cell-mediated apoptosis initiated by granulysin. J Immunol 167(1):350–356

    Article  CAS  PubMed  Google Scholar 

  19. Krensky AM, Clayberger C (2009) Biology and clinical relevance of granulysin. Tissue Antigens 73(3):193–198

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Lan CC, Wu CS, Tsai PC, Chen GS (2006) Diagnostic role of soluble fas ligand secretion by peripheral blood mononuclear cells from patients with previous drug-induced blistering disease: a pilot study. Acta Derm Venereol 86(3):215–218

    Article  CAS  PubMed  Google Scholar 

  21. Louten J, Boniface K, de Waal Malefyt R (2009) Development and function of TH17 cells in health and disease. J Allergy Clin Immunol 123(5):1004–1011

    Article  CAS  PubMed  Google Scholar 

  22. Lowin B, Peitsch MC, Tschopp J (1995) Perforin and granzymes: crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity. Curr Top Microbiol Immunol 198:1–24

    CAS  PubMed  Google Scholar 

  23. Madden DR, Gorga JC, Strominger JL, Wiley DC (1991) The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 353(6342):321–325

    Article  CAS  PubMed  Google Scholar 

  24. Mittmann N, Knowles SR, Koo M, Shear NH, Rachlis A, Rourke SB (2012) Incidence of toxic epidermal necrolysis and Stevens-Johnson syndrome in an HIV cohort: an observational, retrospective case series study. Am J Clin Dermatol 13(1):49–54

    Article  PubMed  Google Scholar 

  25. Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, Parizot C, Taflin C, Heike T, Valeyre D, Mathian A, Nakahata T, Yamaguchi T, Nomura T, Ono M, Amoura Z, Gorochov G, Sakaguchi S (2009) Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30(6):899–911

    Article  CAS  PubMed  Google Scholar 

  26. Morel E, Alvarez L, Cabanas R, Fiandor A, Diaz R, Escamochero S, Prior N, Blanca M, Bellon T (2011) Expression of alpha-defensin 1-3 in T cells from severe cutaneous drug-induced hypersensitivity reactions. Allergy 66(3):360–367

    Article  CAS  PubMed  Google Scholar 

  27. Morel E, Escamochero S, Cabanas R, Diaz R, Fiandor A, Bellon T (2010) CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. J Allergy Clin Immunol 125(3):703–710, 710 e701–710 e708

    Article  CAS  PubMed  Google Scholar 

  28. Moretta L, Romagnani C, Pietra G, Moretta A, Mingari MC (2003) NK-CTLs, a novel HLA-E-restricted T-cell subset. Trends Immunol 24(3):136–143

    Article  CAS  PubMed  Google Scholar 

  29. Murata J, Abe R, Shimizu H (2008) Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment. J Allergy Clin Immunol 122(5):992–1000

    Article  CAS  PubMed  Google Scholar 

  30. Nassif A, Bensussan A, Dorothee G, Mami-Chouaib F, Bachot N, Bagot M, Boumsell L, Roujeau JC (2002) Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis. J Invest Dermatol 118(4):728–733

    Article  CAS  PubMed  Google Scholar 

  31. Pan X, Yuan X, Zheng Y, Wang W, Shan J, Lin F, Jiang G, Yang YH, Wang D, Xu D, Shen L (2012) Increased CD45RA+ FoxP3(low) regulatory T cells with impaired suppressive function in patients with systemic lupus erythematosus. PLoS One 7(4):e34662

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Pichler WJ (2002) Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept. Curr Opin Allergy Clin Immunol 2(4):301–305

    Article  PubMed  Google Scholar 

  33. Pichler WJ (2003) Delayed drug hypersensitivity reactions. Ann Intern Med 139(8):683–693

    Article  CAS  PubMed  Google Scholar 

  34. Pichler WJ (2005) Direct T-cell stimulations by drugs – bypassing the innate immune system. Toxicology 209(2):95–100

    Article  CAS  PubMed  Google Scholar 

  35. Posadas SJ, Padial A, Torres MJ, Mayorga C, Leyva L, Sanchez E, Alvarez J, Romano A, Juarez C, Blanca M (2002) Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity. J Allergy Clin Immunol 109(1):155–161

    Article  CAS  PubMed  Google Scholar 

  36. Reinherz EL (2012) Pharmacology: a false sense of non-self. Nature 486(7404):479–481

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, Auquier A, Bastuji-Garin S, Correia O, Locati F et al (1995) Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 333(24):1600–1607

    Article  CAS  PubMed  Google Scholar 

  38. Saito N, Abe R, Yoshioka N, Murata J, Fujita Y, Shimizu H (2012) Prolonged elevation of serum granulysin in drug-induced hypersensitivity syndrome. Br J Dermatol 167(2):452–453

    Article  CAS  PubMed  Google Scholar 

  39. Satou Y, Utsunomiya A, Tanabe J, Nakagawa M, Nosaka K, Matsuoka M (2012) HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals. Retrovirology 9:46

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Schwartz RA, McDonough PH, Lee BW (2013) Toxic epidermal necrolysis: part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis. J Am Acad Dermatol 69(2):173 e171–113

    Article  PubMed  Google Scholar 

  41. Stur K, Karlhofer FM, Stingl G (2007) Soluble FAS ligand: a discriminating feature between drug-induced skin eruptions and viral exanthemas. J Invest Dermatol 127(4):802–807

    Article  CAS  PubMed  Google Scholar 

  42. Takahashi R, Kano Y, Yamazaki Y, Kimishima M, Mizukawa Y, Shiohara T (2009) Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J Immunol 182(12):8071–8079

    Article  CAS  PubMed  Google Scholar 

  43. Teraki Y, Kawabe M, Izaki S (2013) Possible role of TH17 cells in the pathogenesis of Stevens-Johnson syndrome and toxic epidermal necrolysis. J Allergy Clin Immunol 131(3):907–909. doi:10.1016/j.jaci.2012.08.042

    Article  CAS  PubMed  Google Scholar 

  44. Tohyama M, Shirakata Y, Sayama K, Hashimoto K (2008) A marked increase in serum soluble Fas ligand in drug-induced hypersensitivity syndrome. Br J Dermatol 159(4):981–984

    Article  CAS  PubMed  Google Scholar 

  45. Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, Hunziker T, Saurat JH, Tschopp J, French LE (1998) Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282(5388):490–493

    Article  CAS  PubMed  Google Scholar 

  46. Wei CY, Lee MT, Chen YT (2012) Pharmacogenomics of adverse drug reactions: implementing personalized medicine. Hum Mol Genet 21(R1):R58–R65

    Article  CAS  PubMed  Google Scholar 

  47. Yun J, Adam J, Yerly D, Pichler WJ (2012) Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA. Allergy 67(11):1338–1346

    Article  CAS  PubMed  Google Scholar 

  48. Zhang M, Zhou J, Zhao T, Huang G, Tan Y, Tan S, Fu X, Niu W, Meng G, Chen X, Shang X, Liu D, Ni B, Wang L, Wu Y (2012) Dissection of a circulating and intrahepatic CD4(+)Foxp3(+) T-cell subpopulation in chronic hepatitis B virus (HBV) infection: a highly informative strategy for distinguishing chronic HBV infection states. J Infect Dis 205(7):1111–1120

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, 1-757, Ashimachi-Dori, Niigata, 951-8510, Japan

    Riichiro Abe

Authors
  1. Riichiro Abe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Riichiro Abe .

Editor information

Editors and Affiliations

  1. Department of Dermatology, Kyoto University Grad Sch of Med., Sakyo-ku, Kyoto, Japan

    Kenji Kabashima

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Japan

About this chapter

Cite this chapter

Abe, R. (2016). Cutaneous Adverse Drug Reactions: Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis. In: Kabashima, K. (eds) Immunology of the Skin. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55855-2_24

Download citation

Publish with us

Policies and ethics

Search

Navigation